To answer kevin_tulsa's question specifically:

From a clinical standpoint, Rybelsus on an empty stomach is something I discuss with patients regularly.

The short answer: discuss this specific situation with your prescribing provider.

The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.

Saving this for reference. Quality thread.

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Rybelsus on an empty.

To answer mike_nyc: yes, I am on compounded sema from a 503B pharmacy.

Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Relevant to Rybelsus on an empty stomach — here is my latest bloodwork comparison:

Key improvements: A1C 8.4% → 5.5%, triglycerides 201 → 101 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Want to share my personal experience related to Rybelsus on an empty stomach since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 257 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 10 months later: I am down 82 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Rybelsus on an empty aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.